View clinical trials related to Vasomotor Symptoms; Hot Flashes.
Filter by:The primary objective of this study was to evaluate the frequency of moderate to severe daily hot flashes 4 weeks after a single dose of erenumab (AMG 334) in women with hot flashes associated with menopause.